Literature DB >> 17875110

Paracetamol (acetaminophen) pack size restrictions and poisoning severity: time trends in enquiries to a UK poisons centre.

O Morgan1, L Hawkins, N Edwards, P Dargan.   

Abstract

BACKGROUND AND
OBJECTIVE: In September 1998, legislation was introduced in the United Kingdom to limit paracetamol pack sizes to 16 tablets of 500 mg at general sales outlets and 32 tablets of 500 mg at pharmacies. The effect of the regulations on severity of paracetamol poisoning is unclear. The aim of this study was to describe trends in the severity of paracetamol poisoning and to assess the impact of the 1998 Regulations on the enquiries to a UK poisons centre.
METHODS: We extracted data about the age, sex and number of tablets or capsules of paracetamol ingested by patients notified to Guy's and St Thomas' Poisons Unit (London, UK) between 1996 and 2004. RESULTS AND DISCUSSION: During the study period, there were approximately 140 000 patients with suspected paracetamol poisoning, accounting for around 11% of all patients reported to the poisons unit. The median number of tablets fell from 25 to 20 for males and 20 to 16 for females after 1998. There was also a reduction in the proportion of patients who ingested 17-32 tablets (from 36% to 30%) and 33-100 tablets (from 25% to 19%).
CONCLUSION: Following the 1998 Regulations there was a decline in the severity, but not frequency, of paracetamol poisoning cases reported to Guy's and St Thomas' Poisons Unit. It is unclear whether the decline in severity was a direct consequence of the regulations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875110     DOI: 10.1111/j.1365-2710.2007.00842.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  7 in total

Review 1.  Acetaminophen (APAP) hepatotoxicity-Isn't it time for APAP to go away?

Authors:  William M Lee
Journal:  J Hepatol       Date:  2017-07-20       Impact factor: 25.083

2.  From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006-2015: pharmacological perspectives on regulatory decisions.

Authors:  Eva Barrenberg; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2017-03-28       Impact factor: 2.953

3.  FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): are they reasonable?

Authors:  Garry G Graham; Richard O Day; Andis Graudins; Anthoulla Mohamudally
Journal:  Inflammopharmacology       Date:  2010-03-07       Impact factor: 4.473

4.  [Paracetamol for perioperative analgesia. Old substance - new insights].

Authors:  P K Zahn; R Sabatowski; S A Schug; U M Stamer; E M Pogatzki-Zahn
Journal:  Anaesthesist       Date:  2010-10       Impact factor: 1.041

Review 5.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

6.  Medication Overdoses at a Public Emergency Department in Santiago, Chile.

Authors:  Pablo Aguilera; Marcela Garrido; Eli Lessard; Julian Swanson; William K Mallon; Fernando Saldias; Carlos Basaure; Barbara Lara; Stuart P Swadron
Journal:  West J Emerg Med       Date:  2016-01-12

7.  Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.

Authors:  Thomas Goedecke; Daniel R Morales; Alexandra Pacurariu; Xavier Kurz
Journal:  Br J Clin Pharmacol       Date:  2017-12-20       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.